Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60117-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60117-1-Ig, RRID:AB_2155654
- Product name
- NR2F6 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated NR2F6 antibody (Cat. #60117-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2H2D11
- Vial size
- 20ul, 150ul
Submitted references Melanoma-intrinsic NR2F6 activity regulates antitumor immunity.
Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Kim H, Feng Y, Murad R, Pozniak J, Pelz C, Chen Y, Dalal B, Sears R, Sergienko E, Jackson M, Ruppin E, Herlyn M, Harris C, Marine JC, Klepsch V, Baier G, Ronai ZA
Science advances 2023 Jul 7;9(27):eadf6621
Science advances 2023 Jul 7;9(27):eadf6621
Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway.
Li H, Zhang W, Niu C, Lin C, Wu X, Jian Y, Li Y, Ye L, Dai Y, Ouyang Y, Chen J, Qiu J, Song L, Zhang Y
International journal of cancer 2019 Oct 1;145(7):1921-1934
International journal of cancer 2019 Oct 1;145(7):1921-1934
NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C, Sun X, Zhang W, Li H, Xu L, Li J, Xu B, Zhang Y
International journal of molecular sciences 2016 Oct 20;17(10)
International journal of molecular sciences 2016 Oct 20;17(10)
No comments: Submit comment
No validations: Submit validation data